Butalbital, Aspirin, Caffeine, and Codeine Phosphate (Mayne Pharma Inc.)
Welcome to the PulseAid listing for the Butalbital, Aspirin, Caffeine, and Codeine Phosphate drug offered from Mayne Pharma Inc.. This Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mayne Pharma Inc. |
| NON-PROPRIETARY NAME: | Butalbital, Aspirin, Caffeine, and Codeine Phosphate |
| SUBSTANCE NAME: | BUTALBITAL; ASPIRIN; CAFFEINE; CODEINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-10-30 |
| END MARKETING DATE: | 0000-00-00 |
Butalbital, Aspirin, Caffeine, and Codeine Phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Butalbital, Aspirin, Caffeine, and Codeine Phosphate from Mayne Pharma Inc. |
| LABELER NAME: | Mayne Pharma Inc. |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 50; 325; 40; 30(mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2015-10-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68308-312_6d6c897f-5514-4e8f-ad70-13768bf3490a |
| PRODUCT NDC: | 68308-312 |
| APPLICATION NUMBER: | ANDA203335 |
Other BUTALBITAL; ASPIRIN; CAFFEINE; CODEINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
| Manufacturer / Labeler | Proprietary Name |
| Allergan, Inc. | Fiorinal with Codeine |
| Breckenridge Pharmaceutical, Inc. | Ascomp with Codeine |
| Bryant Ranch Prepack | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE |
| Lannett Company, Inc. | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Mayne Pharma Inc. | Butalbital, Aspirin, Caffeine, and Codeine Phosphate |
| Nexgen Pharma, Inc. | Ascomp with Codeine |
| Physicians Total Care, Inc. | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
